Recent advances in the genetics of schizophrenia.

The high heritability of schizophrenia has stimulated much work aimed at identifying susceptibility genes using positional genetics. As a result, several strong and well-established linkages have emerged. Three of the best-supported regions are 6p24-22, 1q21-22 and 13q32-34 where single studies have achieved genome-wide significance at P<0.05 and suggestive positive findings have also been reported in other samples. Other promising regions include 8p21-22, 6q21-25, 22q11-12, 5q21-q33, 10p15-p11 and 1q42. Recently, evidence implicating individual genes within some of the linked regions has been reported and more importantly replicated. Currently, the weight of evidence supports NRG1 and DTNBP1 as schizophrenia susceptibility loci, though work remains before we understand precisely how genetic variation at each locus confers susceptibility and protection. The evidence for COMT, RGS4 and G72 is promising but not yet persuasive. While it is essential that further replications are established, the respective contributions of each gene, relationships with aspects of the phenotype, the possibility of epistatic interactions between genes and functional interactions between the gene products will all need investigation. The ability of positional genetics to implicate novel genes and pathways will open up new vistas for neurobiological research, and all the signs are that genetic research is poised to deliver crucial insights into the nature of schizophrenia.

[1]  W. Muir Psychiatric genetics and genomics , 2003 .

[2]  G. Kirov,et al.  Detailed analysis of PRODH and PsPRODH reveals no association with schizophrenia , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[3]  Michael C O'Donovan,et al.  A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. , 2003, American journal of human genetics.

[4]  G. Kirov,et al.  Association between PRODH and schizophrenia is not confirmed , 2003, Molecular Psychiatry.

[5]  Ricardo Segurado,et al.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part I: Methods and power analysis. , 2003, American journal of human genetics.

[6]  Leena Peltonen,et al.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. , 2003, American journal of human genetics.

[7]  S. Snyder,et al.  d-serine and serine racemase are present in the vertebrate retina and contribute to the physiological activation of NMDA receptors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[8]  S. Christian,et al.  Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series. , 2003, American journal of human genetics.

[9]  M. Owen,et al.  Cis-acting variation in the expression of a high proportion of genes in human brain , 2003, Human Genetics.

[10]  M C O'Donovan,et al.  Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia , 2003, Molecular Psychiatry.

[11]  Philip D. Harvey,et al.  White matter changes in schizophrenia: evidence for myelin-related dysfunction. , 2003, Archives of general psychiatry.

[12]  M. Gill,et al.  No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based study , 2003, Schizophrenia Research.

[13]  D. Blackwood,et al.  Chromosomal abnormalities and mental illness , 2003, Molecular Psychiatry.

[14]  D. Clair,et al.  A family-based association study of T1945C polymorphism in the proline dehydrogenase gene and schizophrenia in the Chinese population , 2003, Neuroscience Letters.

[15]  Paul J. Harrison,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Genes for Schizophrenia? Recent Findings and Their Pathophysiological Implications , 2022 .

[16]  E. Lander,et al.  Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease , 2003, Nature Genetics.

[17]  O'donovan,et al.  Association between schizophrenia and T 102 C polymorphism of the 5-hydroxytryptamine type 2 a-receptor gene , 2003 .

[18]  Margot Albus,et al.  Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. , 2003, American journal of human genetics.

[19]  Kari Stefansson,et al.  Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. , 2003, American journal of human genetics.

[20]  B. Kerem,et al.  Genome scan of Arab Israeli families maps a schizophrenia susceptibility gene to chromosome 6q23 and supports a locus at chromosome 10q24 , 2003, Molecular Psychiatry.

[21]  P. Sullivan,et al.  Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families. , 2003, Molecular Psychiatry.

[22]  J. Beckmann,et al.  A highly significant association between a COMT haplotype and schizophrenia. , 2002, American journal of human genetics.

[23]  H. Stefánsson,et al.  Neuregulin 1 and susceptibility to schizophrenia. , 2002, American journal of human genetics.

[24]  R. Straub,et al.  Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. , 2002, American journal of human genetics.

[25]  L. DeLisi,et al.  Genome-wide scan for linkage to schizophrenia in a Spanish-origin cohort from Costa Rica. , 2002, American journal of medical genetics.

[26]  I. Gottesman,et al.  The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia , 2002, BMC psychiatry.

[27]  B. Devlin,et al.  Association and linkage analyses of RGS4 polymorphisms in schizophrenia. , 2002, Human molecular genetics.

[28]  John Stewart,et al.  A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. , 2002, The American journal of psychiatry.

[29]  A. Malhotra,et al.  A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. , 2002, The American journal of psychiatry.

[30]  Ellen M Wijsman,et al.  Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P. Sham,et al.  Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. , 2002, Nature Reviews Genetics.

[32]  E. Gershon,et al.  Regional meta-analysis of published data supports linkage of autism with markers on chromosome 7 , 2002, Molecular Psychiatry.

[33]  J D Terwilliger,et al.  Genome-wide scan in a nationwide study sample of schizophrenia families in Finland reveals susceptibility loci on chromosomes 2q and 5q. , 2001, Human molecular genetics.

[34]  J Blangero,et al.  Large upward bias in estimation of locus-specific effects from genomewide scans. , 2001, American journal of human genetics.

[35]  H. Coon,et al.  Genomewide multipoint linkage analysis of seven extended Palauan pedigrees with schizophrenia, by a Markov-chain Monte Carlo method. , 2001, American journal of human genetics.

[36]  D. Garver,et al.  Schizophrenia spectrum disorders: an autosomal-wide scan in multiplex pedigrees , 2001, Schizophrenia Research.

[37]  A. Baldini,et al.  Mice deleted for the DiGeorge/velocardiofacial syndrome region show abnormal sensorimotor gating and learning and memory impairments. , 2001, Human molecular genetics.

[38]  Pat Levitt,et al.  Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse , 2001, Trends in Neurosciences.

[39]  D J Porteous,et al.  Schizophrenia and affective disorders--cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. , 2001, American journal of human genetics.

[40]  S. Shaw,et al.  A schizophrenia-susceptibility locus at 6q25, in one of the world's largest reported pedigrees. , 2001, American journal of human genetics.

[41]  D. Blake,et al.  Dysbindin, a Novel Coiled-coil-containing Protein That Interacts with the Dystrobrevins in Muscle and Brain* , 2001, The Journal of Biological Chemistry.

[42]  D. Blackwood,et al.  Identification of polymorphisms within Disrupted in Schizophrenia 1 and Disrupted in Schizophrenia 2, and an investigation of their association with schizophrenia and bipolar affective disorder , 2001, Psychiatric genetics.

[43]  R. Straub,et al.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[44]  D. Lewis,et al.  Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia , 2001, Molecular Psychiatry.

[45]  W H Wong,et al.  Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M J Owen,et al.  Searching for schizophrenia genes. , 2001, Trends in Molecular Medicine.

[47]  J. Salzer,et al.  Glial Growth Factor/Neuregulin Inhibits Schwann Cell Myelination and Induces Demyelination , 2001, The Journal of cell biology.

[48]  G Kalsi,et al.  Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. , 2001, American journal of human genetics.

[49]  M. Baron,et al.  Genetics of schizophrenia and the new millennium: progress and pitfalls. , 2001, American journal of human genetics.

[50]  S. Tsai,et al.  Association Analysis of a Functional Catechol-O-Methyltransferase Gene Polymorphism in Schizophrenic Patients in Taiwan , 2001, Neuropsychobiology.

[51]  M. S. Pilone,et al.  D-Amino acid oxidase: new findings , 2000, Cellular and Molecular Life Sciences CMLS.

[52]  M. Rietschel,et al.  A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6 , 2000, Molecular Psychiatry.

[53]  P. Holmans,et al.  Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: schizophrenia linkage collaborative group III. , 2000, American journal of human genetics.

[54]  Martin S. Taylor,et al.  Disruption of two novel genes by a translocation co-segregating with schizophrenia. , 2000, Human molecular genetics.

[55]  W. Honer,et al.  Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. , 2000, Science.

[56]  J. Suvisaari,et al.  Genome-wide scan for schizophrenia in the Finnish population: evidence for a locus on chromosome 7q22. , 2000, Human molecular genetics.

[57]  R. Weksberg,et al.  Chromosomal abnormalities and schizophrenia. , 2000, American journal of medical genetics.

[58]  M. Owen,et al.  High rates of schizophrenia in adults with velo-cardio-facial syndrome (VCFS) , 1999, Schizophrenia Research.

[59]  Derek J. Blake,et al.  Different Dystrophin-like Complexes Are Expressed in Neurons and Glia , 1999, The Journal of cell biology.

[60]  J. Suvisaari,et al.  A genomewide screen for schizophrenia genes in an isolated Finnish subpopulation, suggesting multiple susceptibility loci. , 1999, American journal of human genetics.

[61]  M. Owen,et al.  Candidate-gene association studies of schizophrenia. , 1999, American journal of human genetics.

[62]  N. Andreasen,et al.  Follow-up study on a susceptibility locus for schizophrenia on chromosome 6q. , 1999, American journal of medical genetics.

[63]  M. Karayiorgou,et al.  The gene encoding proline dehydrogenase modulates sensorimotor gating in mice , 1999, Nature Genetics.

[64]  C. Stefanis,et al.  Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21 , 1998, Nature Genetics.

[65]  T. Matise,et al.  Genome scan of European-American schizophrenia pedigrees: results of the NIMH Genetics Initiative and Millennium Consortium. , 1998, American journal of medical genetics.

[66]  T. Matise,et al.  NIMH Genetics Initiative Millenium Schizophrenia Consortium: linkage analysis of African-American pedigrees. , 1998, American journal of medical genetics.

[67]  T. Terao,et al.  Association study of a functional catechol-O-methyltransferase gene polymorphism in Japanese schizophrenics , 1998, Neuroscience Letters.

[68]  R. Murray,et al.  Catechol‐O‐methyltransferase polymorphisms and schizophrenia: a transmission disequilibrium study in multiply affected families , 1997, Psychiatric genetics.

[69]  E. Gershon,et al.  Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees. , 1997, Genomics.

[70]  W. Maier,et al.  Evidence suggestive of a locus on chromosome 5q31 contributing to susceptibility for schizophrenia in German and Israeli families by multipoint affected sib-pair linkage analysis , 1997, Molecular Psychiatry.

[71]  R Kucherlapati,et al.  Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? , 1996, The American journal of psychiatry.

[72]  L. Siever,et al.  Additional support for schizophrenia linkage on chromosomes 6 and 8: a multicenter study. Schizophrenia Linkage Collaborative Group for Chromosomes 3, 6 and 8. , 1996, American journal of medical genetics.

[73]  P. Maycox,et al.  Cell death in the Schwann cell lineage and its regulation by neuregulin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[74]  P. Canoll,et al.  GGF/Neuregulin Is a Neuronal Signal That Promotes the Proliferation and Survival and Inhibits the Differentiation of Oligodendrocyte Progenitors , 1996, Neuron.

[75]  R. Weinshilboum,et al.  Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. , 1996, Pharmacogenetics.

[76]  M. Nöthen,et al.  Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene , 1996, The Lancet.

[77]  R. Murray,et al.  A combined analysis of D22S278 marker alleles in affected sib-pairs: support for a susceptibility locus for schizophrenia at chromosome 22q12. Schizophrenia Collaborative Linkage Group (Chromosome 22). , 1996, American journal of medical genetics.

[78]  H. Yoneda,et al.  Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia. , 1996, American journal of medical genetics.

[79]  M. Owen,et al.  No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activity. , 1996, The American journal of psychiatry.

[80]  R. Murray,et al.  Preferential transmission of the high activity allele of COMT in schizophrenia , 1996, Psychiatric genetics.

[81]  Rappold,et al.  Human Molecular Genetics , 1996, Nature Medicine.

[82]  J. Weissenbach,et al.  An international two–stage genome–wide search for schizophrenia susceptibility genes , 1995, Nature Genetics.

[83]  R. Straub,et al.  A potential vulnerability locus for schizophrenia on chromosome 6p24–22: evidence for genetic heterogeneity , 1995, Nature Genetics.

[84]  I. Ulmanen,et al.  Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. , 1995, Biochemistry.

[85]  D. Housman,et al.  Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. , 1994, The Journal of nervous and mental disease.

[86]  T. Kiviluoto,et al.  Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. , 1994, European Journal of Biochemistry.

[87]  D. Collier,et al.  Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. , 1992, Journal of medical genetics.

[88]  R. Shprintzen,et al.  Late-onset psychosis in the velo-cardio-facial syndrome. , 1992, American journal of medical genetics.

[89]  N. Risch Linkage strategies for genetically complex traits. II. The power of affected relative pairs. , 1990, American journal of human genetics.

[90]  A. Farmer,et al.  Is There Really A Split in Schizophrenia? , 1987, British Journal of Psychiatry.

[91]  X. Breakefield,et al.  Soluble and Particulate Forms of Rat Catechol‐O‐Methyltransferase Distinguished by Gel Electrophoresis and Immune Fixation , 1985, Journal of neurochemistry.

[92]  D. Jeffery,et al.  Characterization of Membrane‐Bound and Soluble Catechol‐O‐Methyltransferase from Human Frontal Cortex , 1984, Journal of neurochemistry.